Biological Sciences Division
Published January 16, 2020 | Version v1
Patent Open

IMMUNE RESPONSE MODULATION USING LIVE BIOTHERAPEUTICS, FOR CONDITIONS SUCH AS ALLERGY DESENSITIZATION

Creators

  • 1. University of Chicago
  • 2. Gusto Global LLC

Contributors

Description

Provided herein are compositions (e.g., probiotic, pharmaceutical, etc.) comprising one or more strains of non-Clostridia class bacteria and methods of use thereof for allergen desensitization. In particular, bacteria of bacterial classes such as Negativicutes, Actinobacteria, and Bacteroidia support allergen desensitization, for example, by promoting production of metabolites that aid in desensitization or performing catabolism of food allergens.

Files

US20200016256.pdf

Files (1.9 MB)

Name Size Download all
md5:e23253a4536669014d5a2c390d2d9f51
1.9 MB Preview Download

Additional details

Identifiers

Patent application number
US 201716335636 A
Patent number
US 2020/0016256 A1
Other
oai:uchicago.tind.io:9464

Dates

Patent filed
2017-09-22

UChicago Information

Division(s)
Biological Sciences Division
Department(s)
Ecology and Evolution